US Patent:
20050009776, Jan 13, 2005
Inventors:
Shrikant Gadgil - Deerfield IL, US
William Wheeler - Cary NC, US
Shawn McDonald - Gurnee IL, US
Stephen O'Dell - Midlothian VA, US
Assignee:
Aderis Pharmaceuticals, Inc. - Richmond VA
Fujisawa Healthcare, Inc. - Deerfield IL
International Classification:
A61K031/7076
Abstract:
The present invention relates to the use of N-cyclopentyl-5′-(N-ethyl)carboxamidoadenosine (DTI-0009) or a pharmaceutically acceptable salt or ester thereof in the treatment of atrial fibrillation or atrial flutter in a human. Especially an acute attack of atrial fibrillation or atrial flutter is treated by the method of this invention.